B. Metzler seel. Sohn & Co. AG Has $5.21 Million Holdings in HCA Healthcare, Inc. $HCA

Key Points

• B. Metzler seel. Sohn & Co. AG increased its stake in HCA Healthcare, Inc. by 9.9%, now holding shares worth $5.21 million.
• HCA Healthcare reported a quarterly EPS of $6.84, exceeding analyst expectations, and its revenue rose by 6.4% year-over-year.
• The company announced a quarterly dividend of $0.72 per share, resulting in an annual yield of 0.7% and a payout ratio of 12.11%.

B. Metzler seel. Sohn & Co. AG increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 9.9% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 15,082 shares of the company's stock after purchasing an additional 1,363 shares during the period. B. Metzler seel. Sohn & Co. AG's holdings in HCA Healthcare were worth $5,212,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Cheviot Value Management LLC acquired a new stake in shares of HCA Healthcare during the first quarter worth $26,000. Atwood & Palmer Inc. acquired a new position in HCA Healthcare in the 1st quarter valued at $28,000. Bartlett & CO. Wealth Management LLC grew its holdings in HCA Healthcare by 888.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock valued at $31,000 after buying an additional 80 shares in the last quarter. ORG Partners LLC boosted its holdings in HCA Healthcare by 344.0% during the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock valued at $38,000 after acquiring an additional 86 shares during the period. Finally, Migdal Insurance & Financial Holdings Ltd. grew its stake in shares of HCA Healthcare by 75.8% during the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock worth $40,000 after purchasing an additional 50 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have weighed in on HCA shares. Morgan Stanley decreased their price objective on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a research report on Monday, July 28th. Bank of America lowered shares of HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 target price on the stock. in a research report on Wednesday, July 16th. Royal Bank Of Canada decreased their price objective on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a research note on Monday, July 28th. Wolfe Research cut shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a report on Monday, July 28th. Finally, Stephens raised HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $401.83.

HCA Healthcare Price Performance

HCA Healthcare stock traded down $3.17 on Friday, reaching $404.11. The company's stock had a trading volume of 996,401 shares, compared to its average volume of 1,129,223. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The company has a market cap of $94.56 billion, a price-to-earnings ratio of 16.99, a PEG ratio of 1.27 and a beta of 1.39. The business's fifty day moving average price is $376.92 and its 200 day moving average price is $356.64.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $18.61 billion for the quarter, compared to analysts' expectations of $18.49 billion. During the same period last year, the firm posted $5.50 earnings per share. The business's quarterly revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Equities analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.7%. HCA Healthcare's dividend payout ratio is currently 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.